Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of intravitreal dexamethasone implant for macular edema after retinal vein occlusion
2004-002496-17Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in Vein occlusion (RVO), branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) (3 arms), sponsored by Allergan. Primary endpoint: Best Corrected Visual Acuity. Started Dec 2004; status: completed.
02
Drugs
dexamethasone
03
Conditions
Vein occlusion (RVO)branch retinal vein occlusion (BRVO)central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on 2004-002496-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002496-17.